Feng et al. and our group also reported that disease onset, disease progression, and survival in ALS mouse models were prolonged by the treatments of specific inhibitors of GSK-3β or materials with GSK-3β inhibitor effects. The gene discussed is GSK3B; the disease is amyotrophic lateral sclerosis.